Stop & Shop Parent Pays $40M On Inflated Drug Price Claims
Stop & Shop's parent company will pay $40 million to resolve allegations it violated the False Claims Act by failing to report discounted prescription drug prices as "usual and customary" in...To view the full article, register now.
Already a subscriber? Click here to view full article